Successfully developing biotech drugs in Europe--IBC biomedical conference. 19-20 November 1998, London, UK.
This conference gave an overview of developing business strategies to capitalize on opportunities in the biotech industry. Although the importance of the biotech sector is clear, it is faced with many and varied business and regulatory problems. Financing, timescales, manufacturing, drug development and drug registration, as well as analysis of the current biotech market were discussed.
Nicolai
C
C
Department of Regulatory Affairs, German Association of Pharmaceutical Industries/BP, Karlstrasse 21, Frankfurt/Main, Germany. Cnicolai@bpi.de